arrow
Back
C

Christoph Wanner

university hospital wurzburg

135H-index
1.3KPaper Count
10.1WCitation Count
Published Papers 493
Publication Date
Abstract Submissions to the Era Congress: What they tell us About Nephrology’S Trajectory
err2026-04-30
err0
errOAAI
errGiuseppe Palladino; Christoph Wanner; Kate Stevens; Patrick B Mark; Serhan Tuglular; Monica Fontana; David Simon; Alberto Ortiz
errShare
errSave
Combination Treatment for Management of Chronic Kidney Disease and Type 2 Diabetes: A Review and Practical Guidance
err2026-04-13
err0
PREAI
errMai Mohsen, BPharm, MScPhm; Tae Won Yi, MD, PhD; Labib Faruque, MBBS, MSc; Calvin Ke, MD,PhD; Joseph A Cafazzo, PhD; Quynh Pham, PhD; Vikas S Sridhar, MD; Adeera Levin, MD; Husam Abdel-Qadir, MD, PhD; Frederik Persson, MD, DMSc; Christoph Wanner, MD; Peter Juni, MD; Javed Butler, MD, MPH, MBA; Nikolaus Marx, MD; David Cherney, MD, PhD; Ayodele Odutayo, MD, DPhil
errShare
errSave
Lucerastat, an oral therapy for Fabry disease: results from a pivotal randomized phase 3 study and its open-label extension
err2026-01-10
err0
errOAAI
errPeter Nordbeck; Ozlem Goker-Alpan; John A. Bernat; Dominique P. Germain; Pilar Giraldo; Ana Jovanovic; Virginia Kimonis; Kathleen Nicholls; Cheryl Rockman-Greenberg; Raphael Schiffmann; Mark Thomas; Anna Tylki-Szymanska; Eric Wallace; Richard W. D. Welford; Michael L. West; Martine Clozel; Aline Frey; Luba Trokan; Markus S. Mueller; Markus Vogler; Christoph Wanner; Derralynn Hughes
errShare
errSave
Reduce bureaucracy in clinical trials now
err2026-01-05
err0
PREAI
errMartin Dreyling; Sara Badreh Wirström; Wolfgang E. Berdel; Natacha Bolaños; Sarah Collen; Loris Brunetta; Sharon Deveson Kell; Jeanette Doorduijn; Tarec Christoffer El-Galaly; Ricardo J. O. Ferreira; Marcela Fajardo-Moser; Alan G. Fraser; Christian Gisselbrecht; Kate Hill; Sanja Kolaček; Denis Lacombe; Marieke Meijer; Richard Mindham; Samantha Nier; Richard Price; Natalia Ramírez Comet; Johanna Tassot; Christoph Wanner; Robin Doeswijk
errShare
errSave
Dose response of PTH and FGF23 to paricalcitol in patients with end-stage renal failure on chronic intermittent hemodialysis
err2025-12-01
err0
PREAI
errMussmaecher, Nicolaus; Mitzner, Steffen; Haas, Christian; Busch, Martin; Ketteler, Markus; Wanner, Christoph; Biggar, Patrick
errShare
errSave
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
err2025-11-06
err0
PREAI
errHiddo J. L. Heerspink; Willem H. Collier; Juhi Chaudhari; Shiyuan Miao; Hocine Tighiouart; Gerald B. Appel; Fernando Caravaca-Fontán; Jürgen Floege; Thierry Hannedouche; Enyu Imai; Tazeen H. Jafar; Julia B. Lewis; Philip K. T. Li; Francesco Locatelli; Bart D. Maes; Brendon L. Neuen; Vlado Perkovic; Ronald D. Perrone; Giuseppe Remuzzi; Francesco P. Schena; Christoph Wanner; Tom Greene; Lesley A. Inker
errShare
errSave
Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL study
err2025-11-01
err0
errOAAI
errFolttmann, Tilla C.; Haas, Antje M.; Chesnaye, Nicholas C.; Jager, Kitty J.; Caskey, Fergus J.; Pippias, Maria; Dekker, Friedo W.; Van Diepen, Merel; Evans, Marie; Torino, Claudia; Vilasi, Antonio; Szymczak, Maciej; Wanner, Christoph; Berg, Anders H.; Drechsler, Christiane
errShare
errSave
Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD
err2025-11-01
err0
PREAI
errWitoslawska, Angelika; Drechsler, Christine; Duarte, Kevin; Girerd, Nicolas; Zannad, Faiez; Rossignol, Patrick; Kleber, Marcus E.; Scharnagl, Hubert; Wanner, Christoph; Marz, Winfried; Laaksonen, Reijo
errShare
errSave
Dosing, treatment patterns and safety of finerenone use in routine care: an interim analysis of the prospective, real-world and observational FINE-REAL study
err2025-11-01
err0
errOAAI
errWheeler, David C.; Pantalone, Kevin M.; Guo, Lixin; Desai, Nihar R.; Correa-Rotter, Ricardo; Nicholas, Susanne B.; Kim, Nan Hee; Zheng, Zihe; Scott, Charlie; Horvat-Broecker, Andrea; Merz, Martin; Wanner, Christoph; Navaneethan, Sankar D.
errShare
errSave
#1891 Causal assessment of CKD-MBD phenotypes and CKD progression through a g-formula analysis—insights from the EQUAL study
err2025-10-21
err0
errOAAI
errLorenza Magagnoli; Mario Gennaro Cozzolino; Fergus Caskey; Claudia Torino; Friedo W Dekker; Marie Evans; MacIej Szymczak; Christoph Wanner; Vianda S Stel; Kitty J Jager; Nicholas Chesnaye
errShare
errSave
Burden of pruritus in older CKD stage 4-5 patients: 7-year follow-up of the EQUAL study
err2025-10-01
err0
errOAAI
errCelebi, Enise; Driehuis, Esmee; Chesnaye, Nicholas; Jager, Kitty J.; Caskey, Fergus; Torino, Claudia; Szymczak, Maciej; Drechsler, Christiane; Wanner, Christoph; Evans, Marie; Dekker, Friedo W.; Hoogeveen, Ellen K.
errShare
errSave
Heart failure outcomes and empagliflozin effects in patients with heart failure and reduced ejection fraction in sinus rhythm or atrial fibrillation: Data from EMPEROR-Reduced
err2025-09-16
err0
errOAAI
errMichael Böhm; Javed Butler; Amr Abdin; Gerasimos Filippatos; João Pedro Ferreira; Stuart J. Pocock; Martina Brueckmann; Anne Pernille Ofstad; Elke Schueler; Christoph Wanner; Faiez Zannad; Stefan D. Anker; Milton Packer;  on behalf of the EMPEROR-Reduced Trial Committees and Investigators
errShare
errSave
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial
err2025-07-08
err0
errOAAI
errJunwen Zhou; Claire Williams; Natalie Staplin; Parminder K. Judge; Kaitlin J. Mayne; Nikita Agrawal; Ryoki Arimoto; Jennifer B. Green; David Z.I. Cherney; Katherine R. Tuttle; Jose Leal; Philip Clarke; Jonathan R. Emberson; David Preiss; Christoph Wanner; Martin J. Landray; Colin Baigent; Richard Haynes; William G. Herrington; Borislava Mihaylova; Tunesi Francesca
errShare
errSave
Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
err2025-06-19
err0
PREAI
errAlberto Ortiz; José Manuel Arreola Guerra; Juliana C.N. Chan; Vivekanand Jha; Holly Kramer; Susanne B. Nicholas; Meda E. Pavkov; Christoph Wanner; Leslie P. Wong; Michael Cheung; Jennifer M. King; Morgan E. Grams; Michel Jadoul; Katherine R. Tuttle
errShare
errSave
Impact of Improved Diagnosis and Treatment on Holistic CKD Burden
err2025-06-06
err0
errOAAI
errNavdeep Tangri; Stacey Priest; Anthony Zara; Bo Ren Long; Jieling Chen; Naveen Rao; Clélia-Elsa Froguel; Breonny Robson; Nick Guldemond; Matthew Eckelman; Ana Flavia Moura; Ralph Audehm; Fiona Adshead; Ming-hui Zhao; Christoph Wanner; Steven Chadban
errShare
errSave
Predicting Hospitalization and Related Outcomes in Advanced Chronic Kidney Disease: A Systematic Review, External Validation, and Development Study
err2025-04-25
err0
errOAAI
errRoemer J. Janse; Jet Milders; Joris I. Rotmans; Fergus J. Caskey; Marie Evans; Claudia Torino; Maciej Szymczak; Christiane Drechsler; Christoph Wanner; Maria Pippias; Antonio Vilasi; Vianda S. Stel; Nicholas C. Chesnaye; Kitty J. Jager; Friedo W. Dekker; Merel van Diepen
errShare
errSave
Cardiometabolic protein expression levels and pathways associated with kidney function decline in older European adults with advanced kidney disease
err2025-04-01
err0
errOAAI
errAylward, Ryan E.; Hayward, Samantha; Chesnaye, Nicholas C.; Janse, Roemer J.; Jonsson, P. Andreas; Torino, Claudia; Demetrio, Antonio; Szymczak, Maciej; Drechsler, Christiane; Dekker, Friedo W.; Evans, Marie; Jager, Kitty J.; Wanner, Christoph; Rayner, Brian; Ben-Shlomo, Yoav; Tiffin, Nicki; Caskey, Fergus J.; Birnie, Kate
errShare
errSave
ABCDE to identify and prevent chronic kidney disease: a call to action
err2025-03-19
err0
PREAI
errCharles J Ferro; Christoph Wanner; Valerie Luyckx; Kate Stevens; Sofia Cerqueira; Rasha Darwish; Beatriz Fernandez Fernandez; David Fiel; Rumen Filev; Manfred Grieger; Antonia Lopez; Merike Luman; Jolanta Malyszko; Milena Krasimirova Nikolova-Vlahova; Fiita Romero; Chrysanthi Skalioti; Carla Alexandra Ribeiro dos Santos Araújo; Ieva Ziedina; Daniel Gallego; Alberto Ortiz; Roser Torra; Raymond Vanholder
errShare
errSave
Rationale and design of the Renal Lifecycle trial assessing the effect of dapagliflozin on cardiorenal outcomes in severe chronic kidney disease
err2025-03-07
err0
PREAI
errWisanne M Bakker; Hiddo J L Heerspink; Stefan P Berger; Christoph Wanner; Sunil V Badve; Clare Arnott; Alferso C Abrahams; Joost C van den Born; Tim C van Faassen; Carlo A J M Gaillard; Mariëlle A C J Gelens; Jose L Górris; Marc H Hemmelder; Lily Jakulj; Rob C M van Kruijsdijk; Dirk R J Kuypers; Peter van der Meer; Jeroen B van der Net; Heleen H Nijmeijer; Marc G Vervloet; Aiko P J de Vries; Michael Walsh; Angela Y Wang; Ron T Gansevoort; the Renal Lifecycle Trial Investigators
errShare
errSave